Olink

Olink®
Part of Thermo Fisher Scientific

Long-term Remission After Cilta-Cel in Multiple Myeloma Is Linked to Diverse T Cells and Low Myeloid Suppression

Blood Advances, 2025

Vieira dos Santos J., Melnekoff D., Aleman A., Mouhieddine T., Montes de Oca R., Wang F., Rajeeve S., Bhalla S., Van Oekelen O., Upadhyaya B., Ghodke-Puranik Y., Leshchenko V., Kim-Schulze S., Rahman A., Afik S., Lewinsky H., Plaks V., Thibaud S., Cho H., Richter J., Rodriguez C., Sanchez L., Rossi A., Richard S., Chari A., Madduri D., Jagannath S., Parekh S., Lagana A.

Disease areaApplication areaSample typeProducts
Oncology
Pathophysiology
Bone Marrow Serum
Olink Target 96

Olink Target 96

Abstract

No abstract

Read publication ↗